Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian Perspective

The advent of anti-HER2 targeted therapies has dramatically improved the outcome of HER2-positive breast cancer; however, resistance to treatment in the metastatic setting remains a challenge, highlighting the need for novel therapies. The arrival of new treatment options and clinical trials examini...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrario, Cristiano, Christofides, Anna, Joy, Anil Abraham, Laing, Kara, Gelmon, Karen, Brezden-Masley, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026432/
https://www.ncbi.nlm.nih.gov/pubmed/35448196
http://dx.doi.org/10.3390/curroncol29040222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026432/
https://www.ncbi.nlm.nih.gov/pubmed/35448196
http://dx.doi.org/10.3390/curroncol29040222

Ejemplares similares